Stay updated with breaking news from Ongoing Research Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global KRAS Inhibitors Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The advancement...
/PRNewswire/ -- The "Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026" report has been added to...
/PRNewswire/ -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The global Trop2...
/PRNewswire/ -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The global Trop2...
Share this article Share this article ResearchAndMarkets.com's offering. Over the past few years, the idea of immunotherapy of ability to manipulate immune cells in targeting tumor cells is gaining momentum in field of cancer therapeutics. Since then scientists have developed a wide range of potential candidates which has shown encouraging results in the management of cancer. The recent clinical success of chimeric antigen receptor in the management of hematological malignancies has clearly led to the explosion in the field of adoptive cell therapy for cancer. Researchers are currently puttin...